Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Stern

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Journal of the American Academy of Dermatology|April 20, 2001
The risk of melanoma in association with long-term exposure to PUVAR S Stern,
Annals of the Academy of Medicine, Singapore|October 1, 1988
The benefits, costs and risks of topical tar preparations in the treatment of psoriasis: considerations of cost effectivenessR S Stern
Journal of the American Academy of Dermatology|November 1, 1982
Bias in the assessment of skin cancer risk in patients with psoriasisR S Stern
The Journal of Investigative Dermatology|October 1, 1994
Ocular lens findings in patients treated with PUVA. Photochemotherapy Follow-Up-StudyR S Stern
Archives of Dermatology|September 1, 1996
Managed care and the treatment of skin diseases. Dermatologists do it less oftenR S Stern
Photodermatology, Photoimmunology & Photomedicine|February 17, 1999
Malignant melanoma in patients treated for psoriasis with PUVAR S Stern
The New England Journal of Medicine|April 13, 1989
When a uniquely effective drug is teratogenic. The case of isotretinoinR S Stern
Archives of Dermatology|December 1, 1986
Record linkage. A powerful tool for epidemiologic analysisR S Stern
District Nursing|January 1, 1972
Treatment of common phobiasR S Stern
JAMA|April 4, 1990
Skin cancer incidence: the effects of surveillance and migrationR S Stern
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Journal of the American Academy of Dermatology|April 20, 2001
The risk of melanoma in association with long-term exposure to PUVAR S Stern,
Annals of the Academy of Medicine, Singapore|October 1, 1988
The benefits, costs and risks of topical tar preparations in the treatment of psoriasis: considerations of cost effectivenessR S Stern
Journal of the American Academy of Dermatology|November 1, 1982
Bias in the assessment of skin cancer risk in patients with psoriasisR S Stern
The Journal of Investigative Dermatology|October 1, 1994
Ocular lens findings in patients treated with PUVA. Photochemotherapy Follow-Up-StudyR S Stern
Archives of Dermatology|September 1, 1996
Managed care and the treatment of skin diseases. Dermatologists do it less oftenR S Stern
Photodermatology, Photoimmunology & Photomedicine|February 17, 1999
Malignant melanoma in patients treated for psoriasis with PUVAR S Stern
The New England Journal of Medicine|April 13, 1989
When a uniquely effective drug is teratogenic. The case of isotretinoinR S Stern
Archives of Dermatology|December 1, 1986
Record linkage. A powerful tool for epidemiologic analysisR S Stern
District Nursing|January 1, 1972
Treatment of common phobiasR S Stern
JAMA|April 4, 1990
Skin cancer incidence: the effects of surveillance and migrationR S Stern
Pageof 20